Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population

Clinical Research in Cardiology

Volumn 105, Issue 7, 2016, Pages 601-612

  Custodis, Florian ^a   Roggenbuck, Ulla ^b   Lehmann, Nils ^b   Moebus, Susanne ^b   Laufs, Ulrich ^a   Mahabadi, Amir Abbas ^b   Heusch, Gerd ^b   Mann, Klaus ^b   Jöckel, Karl Heinz ^b   Erbel, Raimund ^b   Böhm, Michael ^a   Möhlenkamp, Stefan ^b,c  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Krankenhaus Bethanien   (Germany)

Author keywords

Coronary events; Mortality; Resting heart rate

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN I; TROPONIN T;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RESTING HEART RATE; RISK FACTOR; SMOKING; AGE; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLINICAL TRIAL; GERMANY; HEART RATE; KAPLAN MEIER METHOD; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK ASSESSMENT; TIME FACTOR;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; GERMANY; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84955240392     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-015-0956-7     Document Type: Article

References (37)

1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832 (0735-1097(90)90282-T [pii])
2. Böhm M, Borer J, Ford I, Gonzalez-Juanatey JR, Komajda M, Lopez-Sendon J, Reil JC, Swedberg K, Tavazzi L (2013) Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 102:11–22. doi:10.1007/s00392-012-0467-8
3. Böhm M, Reil JC (2013) Heart rate: surrogate or target in the management of heart failure? Heart 99:72–75. doi:10.1136/heartjnl-2012-302301
4. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886–894. doi:10.1016/S0140-6736(10)61259-7
5. Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM (2010) Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 159(612–619):e613. doi:10.1016/j.ahj.2009.12.029
6. Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U (2008) Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 117:2377–2387. doi:10.1161/CIRCULATIONAHA.107.746537
7. Custodis F, Fries P, Müller A, Stamm C, Grube M, Kroemer HK, Böhm M, Laufs U (2012) Heart rate reduction by ivabradine improves aortic compliance in apolipoprotein E-deficient mice. J Vasc Res 49:432–440. doi:10.1159/000339547
8. Custodis F, Gertz K, Balkaya M, Prinz V, Mathar I, Stamm C, Kronenberg G, Kazakov A, Freichel M, Böhm M, Endres M, Laufs U (2011) Heart rate contributes to the vascular effects of chronic mental stress: effects on endothelial function and ischemic brain injury in mice. Stroke 42:1742–1749. doi:10.1161/STROKEAHA.110.598607
9. Custodis F, Schirmer SH, Baumhäkel M, Heusch G, Böhm M, Laufs U (2010) Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol 56:1973–1983. doi:10.1016/j.jacc.2010.09.014
10. Diaz A, Bourassa MG, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26:967–974. doi:10.1093/eurheartj/ehi190
11. Erbel R, Möhlenkamp S, Lehmann N, Schmermund A, Moebus S, Stang A, Grönemeyer D, Seibel R, Mann K, Volbracht L, Dragano N, Siegrist J, Jöckel KH (2008) Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis 197:662–672. doi:10.1016/j.atherosclerosis.2007.02.031
12. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bröcker-Preuss M, Mann K, Siegrist J, Jöckel KH (2010) Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 56:1397–1406. doi:10.1016/j.jacc.2010.06.030
13. Floyd JS, Sitlani CM, Wiggins KL, Wallace E, Suchy-Dicey A, Abbasi SA, Carnethon MR, Siscovick DS, Sotoodehnia N, Heckbert SR, McKnight B, Rice KM, Psaty BM (2015) Variation in resting heart rate over 4 years and the risks of myocardial infarction and death among older adults. Heart 101:132–138. doi:10.1136/heartjnl-2014-306046
14. Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, Investigators S (2014) Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 371:1091–1099. doi:10.1056/NEJMoa1406430
15. Fox K, Ford I, Steg PG, Tendera M, Ferrari R (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807–816. doi:10.1016/S0140-6736(08)61170-8
16. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817–821. doi:10.1016/S0140-6736(08)61171-X
17. Fujiura Y, Adachi H, Tsuruta M, Jacobs DR Jr, Hirai Y, Imaizumi T (2001) Heart rate and mortality in a Japanese general population: an 18-year follow-up study. J Clin Epidemiol 54:495–500
18. Gillman MW, Kannel WB, Belanger A, D’Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 125:1148–1154
19. Gillum RF, Makuc DM, Feldman JJ (1991) Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 121:172–177
20. Heidland UE, Strauer BE (2001) Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104:1477–1482
21. Heusch G (2008) Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br J Pharmacol 153:1589–1601. doi:10.1038/sj.bjp.0707673
22. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J Jr (1990) Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 65:547–553 (0002-9149(90)91029-6 [pii])
23. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD (2010) Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease [data from the treating to new targets (TNT) trial]. Am J Cardiol 105:905–911. doi:10.1016/j.amjcard.2009.11.035
24. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P (2005) Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352:1951–1958. doi:10.1056/NEJMoa043012
25. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113:1489–1494
26. Lonn EM, Rambihar S, Gao P, Custodis F, Sliwa K, Teo KK, Yusuf S, Böhm M (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103:149–159. doi:10.1007/s00392-013-0644-4
27. Möhlenkamp S, Lehmann N, Moebus S, Schmermund A, Dragano N, Stang A, Siegrist J, Mann K, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study I (2011) Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J Am Coll Cardiol 57:1455–1464. doi:10.1016/j.jacc.2010.10
28. Möhlenkamp S, Lehmann N, Schmermund A, Roggenbuck U, Moebus S, Dragano N, Bauer M, Kälsch H, Hoffmann B, Stang A, Bröcker-Preuss M, Böhm M, Mann K, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study I (2009) Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall study. Clin Res Cardiol 98:665–676. doi:10.1007/s00392-009-0054-9
29. Möhlenkamp S, Schmermund A, Lehmann N, Roggenbuck U, Dragano N, Stang A, Moebus S, Beck EM, Schluter C, Sack S, Meinertz T, Taylor A, Jöckel KH, Erbel R (2008) Subclinical coronary atherosclerosis and resting ECG abnormalities in an unselected general population. Atherosclerosis 196:786–794. doi:10.1016/j.atherosclerosis.2007.01.012
30. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S (1997) Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30:1267–1273
31. Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S (2007) Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart 93:940–944. doi:10.1136/hrt.2006.101949
32. Schirmer SH, Degen A, Baumhäkel M, Custodis F, Schuh L, Kohlhaas M, Friedrich E, Bahlmann F, Kappl R, Maack C, Böhm M, Laufs U (2012) Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis. Eur Heart J 33:1223–1231. doi:10.1093/eurheartj/ehr255
33. Schmermund A, Möhlenkamp S, Berenbein S, Pump H, Moebus S, Roggenbuck U, Stang A, Seibel R, Grönemeyer D, Jöckel KH, Erbel R (2006) Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. Atherosclerosis 185:177–182. doi:10.1016/j.atherosclerosis.2005.06.003
34. Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, Jöckel KH, Erbel R (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 144:212–218 (S0002870302000698 [pii])
35. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875–885. doi:10.1016/S0140-6736(10)61198-1
36. Tverdal A, Hjellvik V, Selmer R (2008) Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40–45 years. Eur Heart J 29:2772–2781. doi:10.1093/eurheartj/ehn435
37. Whelton SP, Blankstein R, Al-Mallah MH, Lima JA, Bluemke DA, Hundley WG, Polak JF, Blumenthal RS, Nasir K, Blaha MJ (2013) Association of resting heart rate with carotid and aortic arterial stiffness: multi-ethnic study of atherosclerosis. Hypertension 62:477–484. doi:10.1161/HYPERTENSIONAHA.113.01605